MSVOX Mutual Fund Forecast & Price Targets

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

MSVOX Analyst Rating

Moderate Buy

26 Buy

5 Hold

0 Sell

Based on the consensus analyst ratings on 31 stocks held in MSVOX.

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

MSVOX Analyst Price Target

Average Price Target

$9.08

Based on 31 Wall Street analysts offering 12 month price targets to MSIF Vitality Portfolio Class R6 holdings in the last 3 months. The average price target is $9.08 with a high forecast of $10.82 and a low forecast of $7.21. The average price target represents a 51.00% change from the last price of $6.01.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"4":"$4","11":"$11","5.75":"$5.75","7.5":"$7.5","9.25":"$9.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":10.818,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$10.82</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":9.075,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$9.07</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":7.214,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$7.21</span>\n  </div></div>","useHTML":true}}],"tickPositions":[4,5.75,7.5,9.25,11],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jun<br/>2025","6":"Sep<br/>2025","9":"Dec<br/>2025","12":"Mar<br/>2026","25":"Mar<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n              \n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.4,6.7398461538461545,7.079692307692308,7.419538461538462,7.759384615384615,8.099230769230768,8.439076923076923,8.778923076923077,9.118769230769232,9.458615384615385,9.798461538461538,10.138307692307691,10.478153846153846,{"y":10.818,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.4,6.605769230769231,6.811538461538461,7.017307692307693,7.223076923076923,7.428846153846154,7.634615384615384,7.840384615384615,8.046153846153846,8.251923076923077,8.457692307692307,8.663461538461538,8.869230769230768,{"y":9.075,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.4,6.462615384615385,6.525230769230769,6.587846153846154,6.650461538461538,6.713076923076923,6.775692307692308,6.838307692307692,6.900923076923077,6.963538461538462,7.026153846153846,7.088769230769231,7.1513846153846155,{"y":7.214,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":5.65,"date":1740960000000,"info":"<div>Price: <b>$6<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":5.24,"date":1743465600000,"info":"<div>Price: <b>$5<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":5.4,"date":1746057600000,"info":"<div>Price: <b>$5<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":5.28,"date":1748822400000,"info":"<div>Price: <b>$5<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":5.41,"date":1751328000000,"info":"<div>Price: <b>$5<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":5.45,"date":1754006400000,"info":"<div>Price: <b>$5<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":5.54,"date":1756771200000,"info":"<div>Price: <b>$6<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":5.96,"date":1759276800000,"info":"<div>Price: <b>$6<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":6.18,"date":1762128000000,"info":"<div>Price: <b>$6<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":6.69,"date":1764547200000,"info":"<div>Price: <b>$7<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":6.59,"date":1767312000000,"info":"<div>Price: <b>$7<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":6.55,"date":1769990400000,"info":"<div>Price: <b>$7<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":6.4,"date":1772409600000,"info":"<div>Price: <b>$6<b/></div>","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$10.82

Average Price Target$9.08

Lowest Price Target$7.21

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

MSVOX Stocks With Highest Upside Potential

xxxxxxxxxxxxxxxxxxxxxxxxxxx

MXCT

MaxCyte, Inc.

―

1 Buy

0 Hold

0 Sell

Moderate Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

RARE

Ultragenyx Pharmaceutical, Inc.

―

19 Buy

2 Hold

0 Sell

Strong Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

GPCR

Structure Therapeutics, Inc. Sponsored ADR

―

13 Buy

0 Hold

0 Sell

Strong Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

PCVX

Vaxcyte, Inc.

―

7 Buy

1 Hold

0 Sell

Strong Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

BEAM

Beam Therapeutics, Inc.

―

12 Buy

2 Hold

0 Sell

Strong Buy

―

MSVOX Stocks With Highest Downside Potential

xxxxxxxxxxxxxxxxxxxxxxxxxxx

TXG

10X Genomics

―

4 Buy

9 Hold

0 Sell

Moderate Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

EXAS

Exact Sciences Corp

―

0 Buy

6 Hold

0 Sell

Hold

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

ILMN

Illumina

―

4 Buy

5 Hold

3 Sell

Hold

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

ALGN

Align Technology

―

9 Buy

3 Hold

1 Sell

Moderate Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

ELVN

Enliven Therapeutics, Inc.

―

6 Buy

0 Hold

0 Sell

Strong Buy

―

MSVOX Mutual Fund FAQ

What is MSVOX’s average 12-month price target, according to analysts?

Based on analyst ratings, MSIF Vitality Portfolio Class R6’s 12-month average price target is 9.08.

What is MSVOX’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for MSVOX, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is MSVOX a Buy, Sell or Hold?

MSIF Vitality Portfolio Class R6 has a consensus rating of Moderate Buy which is based on 26 buy ratings, 5 hold ratings and 0 sell ratings.

What is MSIF Vitality Portfolio Class R6’s price target?

The average price target for MSIF Vitality Portfolio Class R6 is 9.08. This is based on 31 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $10.82 ,the lowest forecast is $7.21. The average price target represents N/A Increase from the current price of N/A.

What do analysts say about MSIF Vitality Portfolio Class R6?

MSIF Vitality Portfolio Class R6’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 31 Wall Streets Analysts.

How can I buy shares of MSVOX?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing